Inhibrx Biosciences, Inc. Common Stock (INBX) Stock Price, Quote & AI Analysis

Live INBX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Inhibrx Biosciences, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Inhibrx Biosciences, Inc. Common Stock (INBX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

INBX
Inhibrx Biosciences, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
75.750000
High
77.060000
Low
72.270000
Volume
315,465
VWAP
-
Market Cap
$1,099,471,599.72
52W Range
$10.81 - $94.57
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
May 12, 2026 Q1
Market
EPS Estimate: $-1.2311
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Inhibrx Biosciences, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Inhibrx Biosciences, Inc. Common Stock Overview

Company information

Company Overview

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Company Details
Market Cap
$1.10B
Shares Outstanding
14,607,037
Weighted Shares Outstanding
14,607,036
CEO
Mark Paul Lappe
Address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
Employees
110
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Inhibrx Biosciences, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...